Novartis Pharmaceuticals UK Limited Sustainability Profile
Novartis Pharmaceuticals UK Limited, a prominent player in the global healthcare landscape, is headquartered in Great Britain. Established in 1996, the company has made significant strides in the pharmaceutical industry, focusing on innovative medicines and advanced therapies across various therapeutic areas, including oncology, cardiology, and immunology. With a commitment to research and development, Novartis is renowned for its unique portfolio of prescription medications and cutting-edge treatments that address unmet medical needs. The company has achieved notable milestones, including the launch of groundbreaking therapies that have transformed patient care. As a leader in the pharmaceutical sector, Novartis Pharmaceuticals UK Limited continues to enhance its market position through strategic partnerships and a robust pipeline of products, solidifying its reputation for excellence in healthcare innovation.
DitchCarbon Score
How does Novartis Pharmaceuticals UK Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Novartis Pharmaceuticals UK Limited's score of 72 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Novartis Pharmaceuticals UK Limited's reported carbon emissions
In 2023, Novartis Pharmaceuticals UK Limited reported total carbon emissions of approximately 4.71 billion kg CO2e. This figure includes Scope 1 emissions of about 246 million kg CO2e, Scope 2 emissions of approximately 44 million kg CO2e, and Scope 3 emissions, which accounted for about 4.42 billion kg CO2e. Comparatively, in 2022, the company’s total emissions were approximately 5.24 billion kg CO2e, with Scope 1 emissions at about 259 million kg CO2e, Scope 2 at approximately 107 million kg CO2e, and Scope 3 emissions reaching about 4.83 billion kg CO2e. This indicates a reduction in total emissions of about 530 million kg CO2e from 2022 to 2023. Novartis Pharmaceuticals UK Limited is a current subsidiary of Novartis AG, and its emissions data is cascaded from the parent company. However, there are no specific reduction targets or climate pledges documented for the UK subsidiary. The company is involved in various climate initiatives through its parent organization, which includes commitments to the Science Based Targets initiative (SBTi) and other sustainability frameworks. Overall, Novartis Pharmaceuticals UK Limited is actively working towards reducing its carbon footprint, aligning with broader industry standards and practices in climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2022 | |
|---|---|---|
| Scope 1 | 124,000,000 | 000,000,000 |
| Scope 2 | - | 000,000,000 |
| Scope 3 | - | 0,000,000,000 |
How Carbon Intensive is Novartis Pharmaceuticals UK Limited's Industry?
How Carbon Intensive is Novartis Pharmaceuticals UK Limited's Location?
Novartis Pharmaceuticals UK Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Novartis Pharmaceuticals UK Limited has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Boehringer Ingelheim International GmbH
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.